Join
Live feed
·
PRReleasevia Quantisnow
Citius Pharmaceuticals Inc. logo
TenX Keane Acquisition logo

TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals

ByQuantisnow·Wall Street's wire, on your screen.
CTXR· Citius Pharmaceuticals Inc.TENK· TenX Keane Acquisition
Health CareFinance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTXR (Citius Pharmaceuticals Inc.), TENK (TenX Keane Acquisition) and more on Quantisnow.